TTBK2 Activators

Chemical activators of TTBK2 can influence its activity through their interaction with signaling pathways that TTBK2 is known to be involved in. For instance, Lithium Chloride is recognized for its ability to activate the GSK-3β signaling pathways, which have downstream effects on TTBK2 activity, particularly in the context of tau phosphorylation, where TTBK2 has a significant role. Similarly, GSK-3β inhibitors such as SB 216763, Kenpaullone, Biochanin A, 1-Azakenpaullone, AR-A014418, Tideglusib, CHIR99021, Indirubin-3'-monoxime, and various Paullones (including Alsterpaullone) can all lead to the activation of TTBK2. They achieve this by inhibiting GSK-3β, thereby lifting the inhibitory control GSK-3β typically exerts on the tau phosphorylation pathway, a process in which TTBK2 is an active participant. This disinhibition allows for an increase in TTBK2 activity, linking these chemicals to the activation state of TTBK2.

Furthermore, TDZD-8, a non-ATP competitive inhibitor of GSK-3β, activates TTBK2 by altering the GSK-3β pathway, which is crucial for the regulation of TTBK2 activity. By inhibiting GSK-3β, TDZD-8 disrupts the normal regulatory mechanism and indirectly leads to the activation of TTBK2. H-89, while primarily known as a PKA inhibitor, also has the capacity to influence kinase signaling pathways that intersect with TTBK2's activity. By acting on these overlapping pathways, H-89 can promote the activation of TTBK2. Collectively, these chemicals activate TTBK2 by manipulating the regulatory environment and signaling cascades that TTBK2 is a part of, resulting in its functional activation, which is essential for its role in cellular processes such as tau phosphorylation.